23 May 2019 - Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders fundraise, petition and apply for clinical trials to access medications PHARMAC won't fund.

Baden Ngan Kee edges down the stairs using a black cane topped with a jaguar's head fashioned from silver. He opens the office door leading out to an industrial car park, gives a firm handshake and collapses to the ground.

When he was diagnosed with lung cancer he was given six months to live. That was three years ago. His business savvy has kept him alive. Ngan Kee has been sourcing cut-price medicines from India. They are drugs that would cost $10,000 a month in New Zealand and he's been importing generics, sometimes for as little as $600 a month. PHARMAC won't fund the medication for lung cancer patients.

Read Radio New Zealand article